Related Experiment Videos
Present state of hemorheology
Gerontology
|January 1, 1987
Summary
Hemorheological disturbances, including altered blood flow and viscosity, are common in cerebrovascular disease (CVD) and may also appear in Alzheimer's and Parkinson's diseases.
Area of Science:
- Neuroscience
- Hematology
- Vascular Biology
Background:
- Hemorheological disturbances affect over 50% of patients with cerebrovascular disease (CVD).
- Cerebral blood flow (CBF) is inversely related to blood viscosity.
- Interactions between vessel wall changes, blood viscosity, and plasma fibrinogen are crucial in CVD pathogenesis.
Purpose of the Study:
- To explore the role of hemorheological changes in cerebrovascular disease (CVD).
- To investigate the presence of hemorheological alterations in neurodegenerative conditions like Alzheimer's disease and Parkinson's disease.
- To assess the potential of hemorheological parameters in differentiating Parkinson's disease subtypes.
Main Methods:
- Review of existing literature on hemorheology in neurological disorders.
- Analysis of the relationship between blood viscosity, cerebral blood flow, and plasma fibrinogen.
- Comparison of hemorheological profiles in cerebrovascular disease, senile dementia of Alzheimer type (SDAT), and Parkinson's disease.
Main Results:
- Acute ischemic episodes in CVD are linked to hyperaggregable platelets, increased blood viscosity, hyperaggregable red cells, and elevated plasma fibrinogen.
- Hemorheological changes are observed not only in CVD but also in senile dementia of Alzheimer type (SDAT).
- Similar hemorheological alterations can be present in certain cases of Parkinson's disease.
Conclusions:
- Hemorheological disturbances are a significant factor in cerebrovascular disease.
- The presence of hemorheological changes in SDAT and Parkinson's disease suggests a potential link with vascular contributions to these conditions.
- Hemorheological assessment may aid in distinguishing between idiopathic parkinsonism and Parkinson's disease with high hemodynamic risk.